Trial | NCT00148551  Report issue

Title

Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.
Triamcinolone Acetonide as an Adjunctive Treatment to Verteporfin Therapy in Neovascular Age-Related Macular Degeneration: Randomized Placebo-Controlled Clinical Trial.

  • Phase

    Phase 2/Phase 3

  • Study Type

    Interventional

  • Status

    Unknown status

  • Intervention/Treatment

    triamcinolone ...

  • Study Participants

    120
A 24 - month Study looking at the the changes in visual acuity of patients receiving PDT therapy in conjunction with intravitreal triamcinolone.
This study will evaluate the effect of Triamcinolone Acetonide in conjunction with photodynamic therapy for the treatment of sub-foveal choroidal neovascular membranes secondary to age-related macular degeneration.
Study Started
Jan 31
2004
Study Completion
Mar 31
2008
Anticipated
Last Update
Jul 30
2007
Estimate

Drug Triamcinolone Acetonide

Criteria 

Inclusion Criteria:

Individuals with predominantly classic, subfoveal CNV secondary to AMD.
No previous PDT Treatment in study eye.

Exclusion Criteria:

CNV from conditions, other than AMD.
Other disease that could be responsible for decreased vision.
No Results Posted